Josh Abbott

We spoke with representatives from Anthony Nolan and eXmoor to discuss both their collaboration and the importance of ethical cell collection.

A Mississippi mother and a filmmaker discuss the trials and triumphs of supporting the discovery of a gene-therapy program for a rare disease in the US.

The facility is designed the ease advanced therapy development and manufacturing for partners by offering closer collaboration.

We spoke to the facility’s director about the state of CGTs and how the industry can rebuild confidence in advanced modalities.

The investment will strengthen the firm’s US manufacturing while supporting North Carolina’s local economy.

With the future of mRNA vaccines secure, an expert discusses the benefits of vaccine platform diversification.

An expert from GeoVax discusses how China may be poised to overtake the US as the world leader in the industry.

The deal further solidifies a strong 2025 for Matica Bio, which has already surpassed its 2024 revenue.

At September’s Biotech Week Boston (BWB), a speaker advised delegates on how to assess biotechnology innovations to maximize their chances of success.

The project is part of the firm’s $50 billion US investment plan in medicines manufacturing and R&D by 2030.